Enter your search term below:
Join us as we hear from two Korean companies working to bring NK cell-based therapies to market. Both CAR-modified NK cells to treat malignant and recurrent blood cancers as well as combination therapy of NK cells and local immunogenic chemotherapy to treat hepatocellular carcinoma will be...
ISCT Webinar_Natural Killer (NK) Cell-based Strategies-06-28.mp4